With funds reaching almost EUR 140 million and leveraging an additional €100 million from the pharmaceutical industry, the Commission rapidly allocated the funds to 13 research projects on potential treatments, vaccines and diagnostic tests, through an emergency procedure under Horizon 2020 and the Ebola+ call of the Innovative Medicines Initiative.
Need vahendid jagas komisjon programmi „Horisont 2020" ja innovatiivsete ravimite algatuse projektikonkursi „Ebola+" raames kiirmenetluse korras 13 uurimisprojektile, mis tegelesid ravivõimaluste, vaktsiinide ja diagnostiliste testidega.